J Immunother Cancer 2021 Feb
Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade.
Related Questions
New answer by Medical Oncologist at The Ohio State University School of Medicine (October 17, 2022)
This is a good question and unfortunately becoming more frequent. The bottom line is that to my knowledge at least, we have no good prospective data - let alone results of ran...